NewsBenzingaブリーズ・ファーマシューティカルズ、アッヴィとの2024年ライセンス契約の価値は、ブリーズの前臨床段階の片頭痛プログラム2件で最大7億7500万ドルに達する可能性があると発表 ブリーズ・ファーマシューティカルズ、アッヴィとの2024年ライセンス契約の価値は、ブリーズの前臨床段階の片頭痛プログラム2件で最大7億7500万ドルに達する可能性があると発表 Benzinga 2026.11.02 14:06 (GMT+0) Open on Benzinga Other news ‘The Odds Are Almost Zero’: Scott Galloway Doesn’t See Jensen Huang Returning to Nvidia Analysis: Hyperliquid's Stock and Commodity Trading Revenue Grows 6x, Reducing Reliance on Crypto Market Grayscale: Multiple Factors Have Turned Crypto Valuations Oversold; Current Levels Are a Medium- to Long-Term Buying Opportunity for Bitcoin Bitcoin Lightning Network Developers Patch LND Flaw That Could Wipe Payment Records After Node Restart Canton Strategic Holdings Q3 Revenue of $3.05M, Net Loss Widens to $35.1M StablecoinX Q3 Revenue Reaches $478,000, Net Loss $100 Million
Analysis: Hyperliquid's Stock and Commodity Trading Revenue Grows 6x, Reducing Reliance on Crypto Market
Grayscale: Multiple Factors Have Turned Crypto Valuations Oversold; Current Levels Are a Medium- to Long-Term Buying Opportunity for Bitcoin
Bitcoin Lightning Network Developers Patch LND Flaw That Could Wipe Payment Records After Node Restart